Rick Wise's Stock Ratings

Stifel Analyst

Rick Wise is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 02/05/2025

Overall Average Return

14.2%

Smart Score

Overall Average Return Percentile

67th

Number of Ratings

261

Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion

Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business changes for 2025.

11 Analysts Have This To Say About Edwards Lifesciences

This Coca-Cola Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

A Glimpse Into The Expert Outlook On Stryker Through 14 Analysts

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth

Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings growth projected for 2025.

Starbucks To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Wednesday

Deep Dive Into Abbott Laboratories Stock: Analyst Perspectives (6 Ratings)

Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Why Is Abbott Stock Trading Higher On Thursday?

Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes Care and Medical Devices.

Beyond The Numbers: 7 Analysts Discuss Zimmer Biomet Holdings Stock

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

Benzinga Pro on Macbook